In human and experimental diabetes, the relationship subunits, B50 (GAP-43) and α-tubulin were unchanged from controls at 2 months, but were decreased by 26-between molecular abnormalities in perikarya of sensory neurons and structural abnormalities in their distal axons 46% at 6 months. These changes accompanied declines in Nf numbers and densities within large myelinated is largely unexplored. In this study we examined neurofilament (Nf) and tubulin messenger RNA (mRNA) sensory axons, and Nf numbers in unmyelinated fibres by 6 months. Microtubule numbers and densities were expression and their incorporation into distal sensory axons during progressive streptozotocin-induced diabetes similarly reduced in large myelinated axons, and microtubule numbers reduced in small myelinated and in rats. After 2 and 6 months of diabetes, we measured mRNA levels of all three Nf subunits, B50 [growth unmyelinated axons in diabetes at 6, but not 2 months. Axonal atrophy was observed in unmyelinated fibres at associated protein-43 (GAP-43)] and α-tubulin in L4-L6 dorsal root ganglia using Northern analysis. The same 6 months. Our findings indicate that decreased mRNA expression of cytoskeletal proteins in sensory neurons animals underwent morphometric studies of myelinated fibres by light microscopy and quantitative analysis of accompanies a reduction in their incorporation into distal axons. These changes imply that there is a direct link Nf and microtubule numbers and density within sural myelinated and unmyelinated axons. Multifibre in vivo between pathological changes in the sensory neuron and alterations of its distal branches from experimental sensory and motor conduction nerve recordings confirmed slowing of conduction velocities in diabetic rats indicating diabetes. The changes in gene expression in diabetes are unique and differ from those that develop after axotomy. experimental neuropathy. mRNA levels for the three Nf
Introduction
A distal sensory polyneuropathy is the most common form deficiency could result from a defective perikaryal synthesis, abnormal transport or an increased turnover in the axon. of peripheral nerve disorder in diabetic subjects. The role of sensory ganglia dysfunction in this condition is largely Recently, Mohiuddin and colleagues (Mohiuddin et al., 1995) suggested that experimental diabetes was associated with a unexplored and it is uncertain whether abnormalities at the perikaryal level might predict structural abnormalities in decline in the expression of two of the three Nf subunits in sensory neurons. However, it is not known whether such distal axons (Zochodne, 1996a) . Neurofilaments (Nfs) are major determinants of axonal calibre, particularly of large alterations in Nf gene expression or those of tubulin correlate with abnormalities in conduction velocity, myelinated fibre myelinated axons. Correlations between Nf gene expression, axonal calibre and axonal Nf content occur during calibre or incorporation of Nfs and microtubules into distal axons. development, maturation, regeneration and ageing (Hoffman et al., 1985 (Hoffman et al., , 1987 Muma et al., 1990 Muma et al., , 1991 Scott et al., In the present study, we examined whether early or longerterm streptozotocin (STZ)-induced diabetes was associated 1991; Tetzlaff et al., 1991; Parhad et al., 1995) . Axonal Nf with progressive alterations of Nf and α-tubulin messenger
Multifibre nerve conduction recordings
RNA (mRNA) expression in lumbar sensory ganglia. The
Multifibre in vivo nerve conduction recordings were made results of neuronal gene expression were then compared with prior to the injection of STZ or buffer and repeated at 2 quantitative studies of fibre calibre, and of sural axonal Nf and 6 months. Recordings were made in anaesthetized rats and microtubule incorporation. The findings suggested an (pentobarbital 65 mg/kg, i.p.) and included measurements of important relationship.
sensory caudal (the nerve is mixed motor and sensory but conduction velocity is determined by the faster conducting sensory fibres) and sciatic-tibial motor conduction (Zochodne and Ho, 1992) . Subcutaneous near nerve temperatures were
Material and methods

Experimental design
The experimental protocol was reviewed and approved by the University of Calgary Animal Care Committee. Male Sprague-Dawley rats of initial weight 230-300 g (age~12 weeks) were randomly divided and injected with either a single dose of i.p. (intraperitoneal) STZ (Zanosar, Upjohn; 65 mg/kg) in citrate buffer, or an equal volume of citrate buffer alone. Blood glucose measurements were made 5-7 days after injection and the rats were considered diabetic only if the values were ജ12 mmol/l throughout the studies (measured at 7 days, 2 months and 6 months following injection). Glucose measurements were made from the ventral caudal vein using a glucometer (Accuchek II; BoehringerMannheim, Laval, Quebec, Canada). The rats were housed in grouped plastic-bottomed cages with free access to rat chow and water. Rats were sacrificed at 2 and 6 months with C for Northern analysis. The sural nerves distal to the diabetics; n ϭ 8 controls) and 6 months (n ϭ 7 diabetics; sciatic trifurcation were dissected for morphometric n ϭ 7 controls) in both sets of nerve fibres. *Diabetic versus nondiabetic, P ഛ 0.05.
analysis. 
Northern analysis
Latencies were measured to the onset of the negative Total RNA was isolated from L4-L6 dorsal root ganglia deflection of the potential, and amplitudes calculated from using the acid guanidinium thiocyanate-phenol-chloroform baseline to peak. extraction technique (Chomczynski and Sacchi, 1987) . Gel fractionation, transfer to nylon membranes and repeated Northern hybridization were performed as previously described (Parhad et al., 1995) . Each membrane contained samples from several animals of both experimental groups at each time point. Hybridizations were performed at high stringency [hybridized at 60°C and washed at 65-70°C with 0.1 ϫ SSC (standard saline citrate); 1 ϫ SSC ϭ 0.15 M sodium chloride and 0.15 M sodium citrate] and the membranes were exposed to Kodak X-ray film for 16-48 h. The density and area of specific bands on autoradiograms were quantified by video densitometry (Bioquant System IV; R & M Biometrics Inc., Nashville, Tenn., USA) as previously described (Parhad et al., 1992) . The ethidium bromide-stained 28S and 18S bands on the filters were similarly quantified, and the sum of the two bands was used as the denominator for the Northern blots. For each diabetic mRNA, the data were normalized to the value of the control non-diabetic dorsal root ganglia sample.
Selection of cDNA probes
Probes were prepared from the following clones: a 2-kb mouse Nf-light subunit (Nf-L) cDNA, a 660-bp mouse Nf-medium subunit (Nf-M) cDNA and a genomic BglII fragment of the mouse Nf-heavy subunit (Nf-H) (Julien et al., 1986) ; a 1.1-kb rat B50 (GAP-43) cDNA encompassing the full coding sequence (Basi et al., 1987) ; and a 192 bp MboII fragment of mouse α 1 -tubulin cDNA consisting exclusively of the 3Ј-untranslated region. This last region is specific for α 1 -tubulin and shows extensive homology among species. The DNA clones were amplified and purified by standard techniques (Sambrook et al., 1989) and labelled with [α-32 P]dCTP for Northern analysis a random prime labelling kit (Boehringer-Mannheim) to at 2 months (A) and 6 months (B). There was a trend towards fewer myelinated fibres at 6 months, particularly small fibres.
specific activities Ͼ1 ϫ 10 9 c.p.m./µg. 
Morphometric analysis Statistical analysis
The data were expressed as mean Ϯ standard error of the Sural nerves from diabetic and non-diabetic rats 2 and 6 months after STZ and citrate injection, respectively, were mean. For comparison of two means, the data were analysed with either a two-sample (unpaired) Student's t-test or nonharvested for light and electron microscopic analysis. At the sampled level the nerves were largely monofascicular. The parametric (Mann-Whitney) test. For electron microscopy, statistical analysis was based on n ϭ number of rats studied. nerves were immersion fixed in glutaraldehyde (2.5%) buffered with cacodylate (0.025 M) overnight, dehydrated in graded alcohols, stained with osmium tetroxide and embedded in epon. Epon sections of 1 µm were stained with toluidine Results blue, and myelinated fibres were counted and sized using a video-computer image analysis program (Auer, 1994) .
Diabetic and electrophysiological assessment
Diabetic rats had hyperglycaemia and gained less weight Electron micrographs with a final magnification ϫ24 000 (large myelinated axons) and ϫ40 800 (small myelinated than non-diabetic rats over both study periods. Results of the final weights and glucose levels are given in Table 1 . and unmyelinated axons) were used for the measurement of axonal size and analysis of the axonal cytoskeleton. Randomly
Multifibre in vivo sensory and motor nerve conduction recordings confirmed slowing of conduction velocities in the selected myelinated and unmyelinated fibres from each nerve fascicle were measured. At least six large (ജ6 µm diameter) diabetic animals in the caudal sensory and sciatic-tibial motor fibres at both 2 and 6 months, compared with controls and six small (ഛ6 µm diameter) myelinated axons and 50 unmyelinated axons were evaluated for each of three diabetic (Fig. 1) . and control animals. Nf counting was carried out by an observer blinded to the treatment group. For the large myelinated fibres, we chose the largest fibres observed that Nf mRNA levels in diabetic dorsal root ganglia were technically suitable for electron microscopic counting. The axonal area was measured using a video-computer image neurons mRNA levels for Nf-L, Nf-M and Nf-H in diabetic animals analysis program (Auer, 1994) . Nfs and microtubules cut perpendicularly were counted within the total axonal area of were unchanged from controls at 2 months. Similarly, B50 (GAP-43) and α-tubulin were comparable with controls at 2 each fibre. For each rat mean values were calculated from the above and the means and standard errors then calculated months. At 6 months, however, all three Nf subunit mRNA levels had significantly declined by between 26 and 46%. for each group. Comparable declines in B50 (GAP-43) and α-tubulin mRNA 2. At 2 months there was a slight but non-statistical shift towards fewer, larger fibres and increased numbers of smaller levels were observed. Results are given in Table 2 . myelinated fibres in the diabetic rats, with a borderline reduction of mean fibre diameter suggesting mild axonal Light microscopic morphometry atrophy (Table 3) . However, axonal diameter, fibre area and Results of the light microscopic morphometry studies are axonal areas were comparable between the diabetic and nondiabetic rats. At 6 months there was no definite evidence of given in Table 3 and myelinated fibre size histograms in Fig.   Fig. 3 Comparison of the electron micrographs from small myelinated (upper) and unmyelinated (lower) fibres of diabetics (right) and non-diabetics (left). Diabetic axons have fewer Nfs and microtubules. Note the atrophy of the diabetic unmyelinated fibres (ϫ36 312). fibre atrophy using light microscopy despite a borderline small myelinated fibres and unmyelinated fibres (Figs 3 and 4). significant trend shown with the electron microscopy studies (see below). There was a non-significant trend towards decreased numbers of myelinated fibres and myelin thinning in diabetic rats at 6 months.
Discussion
The major findings from this work were: (i) early (2 month) and later (6 month) experimental diabetes were associated Electron microscopic morphometry of the with reductions in motor and sensory conduction velocities; (ii) there was a substantial decline in the expression of all
axonal cytoskeleton
Comparison of the axonal cytoskeleton for diabetic and three Nf subunits, of α-tubulin and of B50 (GAP-43) by 6, but not by 2 months of diabetes; (iii) comparable declines in control rats is summarized in Table 4 . In non-diabetic rats there was an increase in the cross-sectional axonal area and the diabetic rats at 6, but not 2 months were observed in the incorporation of Nf and microtubules into axons, most a trend towards increasing numbers of Nfs, with decreased Nf density between 2 and 6 months. In contrast, small noticeably in large myelinated fibres, but this was not associated with atrophy. Borderline atrophy was observed in myelinated fibres and unmyelinated fibres had similar Nf content at the two time points. Microtubule numbers increased small myelinated fibres and definite atrophy was seen in unmyelinated fibres; (iv) changes in gene expression predicted between 2 and 6 months in non-diabetic rats.
There was no difference in the number of axonal Nfs or those of axonal structure; (v) the pattern of progressive impairment of gene expression differed substantially from Nf density between diabetic and control rats at 2 months. At 6 months there was a reduction in Nf numbers and Nf density that expected from axotomy. Nfs are the major intermediate (10 nm) filaments in many in large myelinated fibres of diabetic rats, compared with controls. In small myelinated fibres there were non-significant types of mature neurons. Assembled as obligate heteropolymers of three polypeptide subunits, Nf-L, Nf-M trends toward fewer numbers of Nfs and axonal atrophy. Nf numbers, but not density, were reduced in unmyelinated and Nf-H, Nfs are the most abundant cytoskeletal component in large myelinated axons, particularly those arising from fibres and there was axonal atrophy. Microtubule numbers and densities were not reduced in large or small myelinated large lower and upper motor and sensory neurons. The quantity of Nf proteins within an axonal segment is fibres, or unmyelinated fibres at 2 months. At 6 months there were declines in microtubule numbers and density in large determined by the rates of Nf synthesis, transport, phosphorylation and degradation. During development and myelinated fibres and a decline in microtubule numbers in maturation there is an increase in Nf mRNA levels, a expression with alterations in conduction velocity. There was no relationship. decrease in the rate of Nf transport and an increase in Nf-H The most consistent morphometric finding reported in phosphorylation, each of which contributes to the increased animals rendered diabetic before the cessation of their growth quantity of Nf proteins within the axon (Carden et al., 1987;  period has been a slight reduction in myelinated fibre size in Dahl, 1988; McQuarrie et al., 1989; Muma et al., 1991) .
diabetic animals compared with age-matched controls Following axotomy, a decrease in Nf gene expression appears (Sharma et al., 1981; Mattingly and Fischer, 1985 ; Thomas to predict declines in axon calibre (Hoffman et al., 1987 (Hoffman et al., ). et al., 1990 . This change has been postulated to be due to Previous reports have suggested that changes of axonal calibre a retardation in normal growth rates secondary to diabetes. in STZ-induced diabetic rats are secondary to reductions in However, other studies have described a proximal increase axonal Nf and microtubule content, in turn caused by diabetesand distal decrease in axonal calibre in STZ-induced related impairment of slow axonal transport (Medori et al., neuropathy that is associated with changes in axonal Nf 1988a, b; Macioce et al., 1989) . Our study suggests instead number and explained by impaired anterograde axonal that decreased Nf and α-tubulin mRNA expression, and an transport (Medori et al., 1988a) . The slower axonal transport impaired Nf and tubulin supply directly predict declines in of Nfs is thought to lead to a thickening of the axons in the the axonal incorporation of Nfs and microtubules. Altered proximal segments and to a reduction of axonal calibre in axonal insertion was most obvious in large myelinated fibres the distal parts. A complicating factor is that most studies and unmyelinated fibres. A similar trend was observed in evaluating the effects of experimental diabetes on nerve fibre smaller myelinated fibres, but was not statistically significant, size and Nf content have included rats that had not yet possibly because there are fewer Nfs to sample in this reached full maturity (Medori et al., 1988a; Mohiuddin et al., population . The relationship of this incorporation to axonal 1995). Some investigators have questioned whether smaller atrophy, however, was less robust in myelinated fibres. We axonal size is simply due to a delay in maturation rather than did not observe significant atrophy except in unmyelinated active axonal atrophy (Thomas et al., 1990; Weis et al ., fibres at 6 months. Since many more fibres are sampled using 1995). In contrast, other reports using more mature or older light microscopy, we relied on this technique to draw our diabetics (Wright and Nukada, 1994) , as in our 6-month final conclusions about myelinated fibre calibre. It is possible work, have found no significant differences in axonal calibre that changes in structural proteins, however, are associated between control and diabetic groups. Unmyelinated fibres with more distal sensory terminal atrophy or retraction that have not been studied. As in previous work using this model, we did not specifically seek. Yagihashi and colleagues also a lesser weight gain was observed in diabetic rats compared observed a reduction in Nf content of sural myelinated fibres with controls. While this raises a concern that changes that exceeded the loss predicted by axon size (Yagihashi observed may reflect a nutritional deficiency, we observed et al ., 1990 ). In their model, axonal atrophy was more altered gene expression at the 6-month mark, whereas prominent in myelinated fibres after 7 months of diabetes, differences in weight gain were much more pronounced at 2 and they postulated that reductions in neuronal synthesis of months when gene expression was unaltered. Our choice Nfs accounted for their findings.
of a 6-month time point was a deliberate approach to Our results probably lend support to those of Mohiuddin this problem. and colleagues who suggested that expression of two of the Overall, our findings suggest that in experimental diabetes three Nf subunit mRNAs declines in short-term (2 months) of sufficient duration there are less than direct connections experimental diabetes (Mohiuddin et al., 1995) . While we between changes in conduction velocity, axonal calibre and did not observe changes by 2 months, differences in rat strain axonal incorporation of structural proteins. Each may change susceptibility and diabetes intensity could account for the in parallel during diabetes but for separate reasons at different time differences. We confirmed, however, that Nf synthesis times. It may be that declines in gene expression of structural does decline by 6 months and that it is substantial and proteins will become a better predictor of distal sensory involves all three Nf subunits. Such a decline could reflect terminal retraction and loss, the most important feature of fewer neurons producing Nf, but we did not observe a clinical sensory loss in diabetes. Conduction velocity changes statistically significant decline in sural fibre numbers despite in diabetes are probably better accounted for by metabolic a trend in this direction. Accurate neuronal counts without changes, such as sodium accumulation in axons or sodium bias using a dissector approach and in a long-term study of channel migration out of nodes of Ranvier (Greene et al., diabetes have not been published. We also think it is unlikely 1987; Cherian et al., 1996) . that Nf mRNA was somehow 'diluted' by a large increase Axotomy of peripheral nerves normally provokes changes in the non-neuronal cell population. Moreover, the mRNA in synthesis of neuronal proteins thought to be necessary for findings matched the electron microscopy counts of Nf axonal regeneration. Sciatic nerve section causes a marked protein. Separate work in 12-month diabetic rats has identified decrease in Nf, and marked increases in B50 (GAP-43) and Nf mRNA reductions using quantitative in situ hybridization tubulin mRNA levels in the lumbar dorsal root ganglia (Scott (D. W. Zochodne and V. M. Verge, unpublished data). Finally, et al., 1991; Scott and Parhad, 1994; Verge et al., 1996) , even in the diabetic state (Pekiner et al., 1996) . Nerve growth unlike previous work, we also compared the changes in gene
